Elisha M. Wachman, MD
Professor, Pediatrics
Biography
Dr. Wachman is a Professor of Pediatrics at the BU Chobanian & Avedisian School of Medicine and attending neonatologist at Boston Medical Center (BMC). She is currently the Vice Chair for Research in the Department of Pediatrics at BMC, and the Co-Director of the BU CTSI Integrated Pilot Grant Award Program. She is a nationally recognized clinical and translational researcher with expertise in neonatal opioid withdrawal syndrome (NOWS) and substance use disorders in pregnancy. Her specific research interests include the genetics and epigenetics of NOWS, treatments for opioid use disorder (OUD) in pregnancy, and the use of non-pharmacologic care methods to improve NOWS outcomes. She is currently the principal investigator on two NIH studies examining opioid use disorder in pregnancy, genetic markers, and long-term maternal and infant outcomes. She also leads several other NIH and foundation funded studies involving pregnant individuals with OUD / infants with NOWS.
Other Positions
- Co-Director, Integrated Pilot Grant Award Program, Clinical and Translational Science Institute, Boston University
Education
- Boston University School of Medicine, MD
- Georgetown University, BS
Publications
- Published on 4/2/2024
Singh R, Melvin P, Wachman EM, Rothstein R, Schiff DM, Murzycki J, VanVleet M, Gupta M, Davis JM. Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches. J Perinatol. 2024 Apr 02. PMID: 38565652.
Read at: PubMed - Published on 2/14/2024
Wachman EM, Saia K, Bressler J, Werler M, Carter G, Jones HE. Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder. J Addict Med. 2024 Feb 14. PMID: 38354121.
Read at: PubMed - Published on 1/27/2024
Parker SE, Annapragada B, Chestnut IA, Fuchs J, Lee A, Sabharwal V, Wachman EM, Yarrington CD. Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy. Hypertens Pregnancy. 2024 Dec; 43(1):2308922. PMID: 38279906.
Read at: PubMed - Published on 1/1/2024
Mascarenhas M, Wachman EM, Chandra I, Xue R, Sarathy L, Schiff DM. Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2024 Jan 01; 153(2). PMID: 38178779.
Read at: PubMed - Published on 1/1/2024
Bektas G, Soderborg T, Slater C, Agarwal J, Racioppi M, Hogan T, Werler MM, Wachman EM. Retraction Note: The Neonatal Withdrawal Assessment Tool (NWAT): pilot inter-rater reliability and content validity. J Perinatol. 2024 Jan; 44(1):155. PMID: 37996662.
Read at: PubMed - Published on 12/31/2023
Morrison TM, Schiff DM, Olson A, Hunter RG, Agarwal J, Work EC, Muftu S, Shrestha H, Boateng J, Werler MM, Carter G, Jones HE, Wachman EM. Hair Cortisol Concentrations in Opioid-Exposed versus Nonexposed Mother-Infant Dyads. Am J Perinatol. 2023 Dec 31. PMID: 38160676.
Read at: PubMed - Published on 12/28/2023
Lofwall MR, Young JL, Hansen Z, Wachman EM, Wilder C, Guille C, Charles JE, Leeman L, Gray JR, Winhusen TJ. What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038). J Clin Gynecol Obstet. 2023 Dec; 12(3):110-116. PMID: 38435674.
Read at: PubMed - Published on 10/31/2023
Sabharwal V, Taglauer E, Demos R, Snyder-Cappione J, Shaik-Dasthagirisaheb YB, Parker-Kelleher S, Hunnewell J, Boateng J, Clarke K, Yuen R, Barnett ED, Wachman EM, Yarrington CD. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy. Am J Perinatol. 2023 Oct 31. PMID: 37774748.
Read at: PubMed - Published on 10/20/2023
Tivnan P, Setty BN, Howard E, Agarwal J, Farris CW, Wachman EM, Castro-Aragon I. Ultrasound evaluation of brain parenchyma in preterm infants with prenatal opioid exposure. J Perinatol. 2023 Oct 20. PMID: 37863985.
Read at: PubMed - Published on 10/1/2023
Harris M, Schiff DM, Saia K, Muftu S, Standish KR, Wachman EM. Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023). Breastfeed Med. 2023 Oct; 18(10):715-733. PMID: 37856658.
Read at: PubMed
View 75 more publications: View full profile at BUMC